GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?

Jon Whitehead, Meng-Wong Taing, Felicity Rose
  • Drug Design Development and Therapy, June 2014, Taylor & Francis
  • DOI: 10.2147/dddt.s35723

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/dddt.s35723

The following have contributed to this page: Dr Meng-Wong Taing